The Indian pharma industry is set for a great leap forward in the coming years and therefore all the stakeholders should brace up for the development, according to Sanjit Singh Lamba, the Managing Director of Eisai pharma India Private Limited and the president of the Indian chapter of Parenteral Drug Association (PDA).

He said here on Sunday at the valedictory session of the Indian Pharmaceutical Congress that the industry was growing at 15.92 per cent per annum in the country and the size would grow to $ 55 billion by 2020, making India the sixth largest market globally.

He said that especially in the segment of parental segment there was immense scope for growth. He said the PDA was committed to disseminating scientific and technical information and also information relating to the regulatory aspects. Students in particular should become the members of the PDA by paying Rs 6,500-6,800 per annum.

He also stressed the importance of data security in the pharma industry and the steps to be taken for promoting it.

S.V Veerramani, the president of the Indian Drug Manufacturers' Association, said the Government should lend greater support to the pharma sector, as in China, especially to the MSMEs in the pharma sector.

"There is a need to set up a single ministry at the central level for the pharma industry. At present, the industry comes under three to four ministries and it is causing a lot of problems," he said and urged the Union Government to act immediately on the issue.

He said the new state of Andhra Pradesh after bifurcation had great potential to emerge as the pharma hub of the country and he thanked Chief Minister N. Chandrababu Naidu for his support to the industry.

sarma.rs@thehindu.co.in

Related Topics
comment COMMENT NOW